Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Use-Results Survey of Opdivo in Unresectable Malignant Melanoma (All-Case Surveillance)
jRCT1080223217Unknown
- Sponsor
- Ono Pharmaceutical
- Start
- May 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of nivolumab in melanoma (2 arms), sponsored by Ono Pharmaceutical. Status: unknown.
02
Drugs
03
Conditions
melanoma
Beyond the preview
Go deeper on jRCT1080223217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223217.